Sponsor:
University of Southern California
Code:
NCT02717156
Conditions
Stage IV Bladder Urothelial Carcinoma
Prostate Cancer
Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Computed Tomography
Laboratory Biomarker Analysis
Pembrolizumab
Positron Emission Tomography
Recombinant EphB4-HSA Fusion Protein
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Southern California on 2024-02-15.